115 related articles for article (PubMed ID: 2013622)
1. DNA flow cytometry of follicular non-Hodgkin's lymphoma.
Macartney JC; Camplejohn RS; Morris R; Hollowood K; Clarke D; Timothy A
J Clin Pathol; 1991 Mar; 44(3):215-8. PubMed ID: 2013622
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of DNA ploidy in large cleaved cell lymphomas.
Aine R; Lehtinen T; Lehtinen M; Blanco G; Apaja-Sarkkinen M; Leinikki P; Alavaikko M
Hematol Oncol; 1990; 8(6):339-46. PubMed ID: 2286357
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.
Macartney JC; Camplejohn RS; Alder J; Stone MG; Powell G
J Clin Pathol; 1986 May; 39(5):542-6. PubMed ID: 3722408
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry.
Horii A; Yoshida J; Hattori K; Honjo Y; Mitani K; Takashima S; Sakai M; Okamoto S; Kubo T
Head Neck; 1998 Aug; 20(5):392-8. PubMed ID: 9663666
[TBL] [Abstract][Full Text] [Related]
7. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
Joensuu H; Klemi PJ; Jalkanen S
Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
[TBL] [Abstract][Full Text] [Related]
8. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
Christensson B; Tribukait B; Linder IL; Ullman B; Biberfeld P
Cancer; 1986 Sep; 58(6):1295-304. PubMed ID: 3742454
[TBL] [Abstract][Full Text] [Related]
12. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
Smaaland R; Lote K; Sothern RB; Laerum OD
Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material.
Young GA; Hedley DW; Rugg CA; Iland HJ
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1497-504. PubMed ID: 3678313
[TBL] [Abstract][Full Text] [Related]
15. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
16. Ploidy and proliferative activity measurement by flow cytometry in non-Hodgkin's lymphomas. Do speculative aspects prevail over clinical ones?
Cavalli C; Danova M; Gobbi PG; Riccardi A; Magrini U; Mazzini G; Bertoloni D; Rutigliano L; Rossi A; Ascari E
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1755-63. PubMed ID: 2632257
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of DNA ploidy and proliferative activity in Hodgkin's disease.
Joensuu H; Klemi PJ; Korkeila E
Am J Clin Pathol; 1988 Dec; 90(6):670-3. PubMed ID: 3195496
[TBL] [Abstract][Full Text] [Related]
18. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
[TBL] [Abstract][Full Text] [Related]
19. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic significance of proliferative and apoptotic fractions in low grade follicular non-Hodgkin's lymphoma].
Bartkowiak D; Röttinger EM
Strahlenther Onkol; 1996 Sep; 172(9):519-21. PubMed ID: 8928062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
